Senior Director, US Brand Strategy & Launch – Mood Disorders

Role: Senior Director, US Brand Strategy & Launch, responsible for the end-to-end commercialization of Neurocrine’s upcoming Mood Disorders treatment in the US. Responsibilities: develop and execute a comprehensive brand strategy, including positioning, segmentation, messaging, and metrics; lead cross-functional planning aligning marketing, medical, market access, sales, regulatory, and analytics teams; shape engagement strategies for HCPs and patients based on neuropsychiatric landscape insights; manage pre-launch and launch programs; oversee budget and external agencies; represent the brand in governance forums; build external stakeholder relationships; lead and develop a high-performing team; operate in a highly matrixed environment. Requirements: BS/BA in scientific or business discipline with 15+ years relevant experience, including 7+ years in pharma marketing or sales, with prior experience managing external agencies; or Master’s/MBA with 13+ years, or PhD with 10+ years and strong leadership background. Proven success in U.S. brand strategy and launches in neuroscience, psychiatry, or specialty therapeutics; deep understanding of mental health HCP and patient dynamics; ability to influence senior leadership and lead cross-functional teams; excellent communication and stakeholder management skills. High-Value: CNS, Mood Disorders, US commercial launch, HCP and patient engagement, multi-channel marketing, 25-50% domestic travel.